We endorse the information on these websites:•theMS Society website.•theMS Trust website•Shift MSis a social network site for people with MS.•Ablog on MS researchfrom colleagues in London
Clinical Trials in Multiple Sclerosis
Trials in the US, and many in the EU, are listed at the US Clinical Trials websiteClinical Trials in Cambridge are listed here
Alemtuzumab is now licensed for the treatment ofmultiple sclerosis and apporved by NICE, for use in the NHS.It should soon be available at a hospital near you.We are currently running a trial of alemtuzumab for people withrelapsing-remitting multiple sclerosis, based in Cambridge, UK.In this trial, everyone receives alemtuzumab. Half also receive anexperimental drug. Further information is here.